Porcilis® APP Suspension for injection
Porcilis APP contains toxoids produced by Actinobacillus pleuropneumoniae and can be used to immunise pigs against pleuropneumonia. Its use may contribute to the reduction of antimicrobial use.
Presentation
Suspension for injection
Active ingredients
Per 2 ml dose:
- 600 mg Actinobacillus pleuropneumoniae antigen concentrate containing:
- OMP [outer membrane protein] 50 units*
- Apx I toxoid 50 units
- Apx II toxoid 50 units
- Apx III toxoid 50 units
* Units relative to an internal standard determined to be efficacious in pigs
Target species
Pigs (weaned piglets)
Indications for use
Porcilis APP is for the active immunisation of weaned piglets to reduce mortality, clinical signs and lesions of pleuropneumonia caused by Actinobacillus pleuropneumoniae.
Onset of immunity: 2 weeks after completion of the vaccination scheme.
Duration of immunity: 11 weeks after completion of the vaccination scheme.
Withdrawal periods
Pigs – meat: zero days
Packaging
1 glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 100 ml (50 doses).
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: January 2025